血浆催乳素水平与绝经前乳腺癌危险性的关系评估

马瑞兰; 李国权; 徐晓颖; 邹丽娟

doi:10.13898/j.cnki.issn.1000-2200.2015.01.021

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

血浆催乳素水平与绝经前乳腺癌危险性的关系评估

马瑞兰 , 李国权 , 徐晓颖 , 邹丽娟

文章导航 > 蚌埠医学院学报 > 2015, 40 > 1: (64-66)

引用本文:

Citation:

血浆催乳素水平与绝经前乳腺癌危险性的关系评估

大连医科大学附属第二医院肿瘤放疗科, 辽宁大连 116023

作者简介: 马瑞兰(1981-),女,硕士,主治医师.

中图分类号: R737.9

Relationship between plasma prolactin concentration and risk of breast cancer among premenopausal women

Department of Radiation Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian Liaoning 116023, China
CLC number: R737.9

摘要: 目的:评估血浆催乳素(PRL)水平与绝经前女性乳腺癌危险性的关系.方法:采用放射免疫法测定65例绝经前女性乳腺癌患者(病例组)和65例匹配对照者(对照组)的血浆PRL水平,条件logistic回归分析血浆PRL水平与绝经前乳腺癌危险性的关系.根据肿瘤的临床病理特征对病例组再进行分组,评价血浆PRL水平与乳腺癌各亚组危险性的关系.结果:病例组血浆PRL水平显著高于对照组(P < 0.01).血浆PRL水平上四分位数相比下四分位数的调整OR(95%CI)为1.54(0.84～4.07),趋势P=0.031;PRL与绝经前乳腺癌危险性的关系在雌激素受体阳性的肿瘤中稍增强,但不随肿瘤大小、病理类型、肿瘤分级、淋巴结转移情况而变化.结论:血浆PRL水平与绝经前女性乳腺癌的危险性呈正相关,尤其是雌激素受体阳性的乳腺癌患者.
- 乳腺肿瘤 /
- 危险因素 /
- 催乳素 /
- 绝经前
Abstract: Objective:To estimate the association of plasma prolactin(PRL) concentration with the risks of breast cancer among premenopausal women.Methods:The concentration of plasma PRL was measured in 65 premenopausal women with breast cancer and 65 matched control subjects by radioimmunoassay.The relations between the plasma PRL concentration and the breast cancer in premenopausal women were observed using conditional logistic regression analysis.All the cases were grouped according to the pathological features;the association of the level of PRL and the risk of breast cancer for different sub-groups were evaluated.Results:The plasma PRL concentration of the case group was significantly higher than that of the control group.Increased risk of breast cancer was positively related with the elevated plasma concentration of PRL(adjusted odds ratio [OR] for the highest versus the lowest quartile=1.54, 95% confidence interval [95%CI]=0.84-4.07, Ptrend=0.031).The concentration of plasma PRL increased modestly in estrogen receptor positive carcinomas but did not change with the tumor size, grade or lymph node status.Conclusions:The results suggest that high plasma concentration of PRL is positively related with the breast cancer, especially estrogen receptor positive carcinomas among premenopausal women.
- breast neoplasms /
- risk factor /
- prolactin /
- premenopausal

[1]	Clevenger CV,Furth PA,Hankinson SE,et al.The role of prolactin in mammary carcinoma[J].Endocr Rev,2003,24(1):1-27.
[2]	Tworoger SS,Hankinson SE.Prolactin and breast cancer risk[J].Cancer Lett,2006,243(2):160-169.
[3]	Tworoger SS,Sluss P,Hankinson SE.Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women[J].Cancer Res,2006,66(4):2476-2482.
[4]	Tworoger SS,Eliassen AH,Sluss P,et al.A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer[J].J Clin Oncol,2007,25(12):1482-1488.
[5]	Tworoger SS,Eliassen AH,Zhang XH,et al.A 20-Year Prospective Study of Plasma Prolactin as a Risk Marker of Breast Cancer Development[J].Cancer Res,2013,73(5):4810-4819.
[6]	Tikk K,Sookthai D,Johnson T,et al.Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort[J].Ann Oncol,2014,25(7):1422-1428.
[7]	Bhatavdekar JM,Patel DD,Shah NG,et al.Prolactin as a local growth promoter in patients with breast cancer:GCRI experience[J].Eur J Surg Oncol,2000,26(6):540-547.
[8]	Llovera M,Touraine P,Kelly PA,et al.Involvement of prolactin in breast cancer:redefining the molecular targets[J].Exp Gerontol,2000,35(1):41-51.
[9]	李志杰,杜昌国.乳腺良恶性疾病患者血清催乳素、雌二醇水平的比较及其临床意义[J].蚌埠医院学报,2013,38(8):1005-1006.
[10]	Rose-Hellekant TA,Arendt LM,Schroeder MD,et al.Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice[J].Oncogene,2003,22(30):4664-4674.
[11]	Gutzman JH,Miller KK,Schuler LA.Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells[J].J Steroid Biochem Mol Biol,2004,88(1):69-77.
[12]	Rasmussen LM,Frederiksen KS,Din N,et al.Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells[J].Endocr Relat Cancer,2010,17(3):809-822.
[13]	O'Leary KA,Jallow F,Rugowski DE,et al.Prolactin activates ERα in the absence of ligand in female mammary development and carcinogenesis in vivo[J].Endocrinology,2013,154(12):4483-4492.

[1]	李志杰 , 杜昌国 . 乳腺良恶性疾病患者血清催乳素、雌二醇水平的比较及其临床意义. 蚌埠医学院学报, 2013, 37(8): 1005-1006.
[2]	廖洪宇 , 龚建 . 血清CA15-3、CA125、CEA和PRL水平与乳腺癌及骨转移的关系. 蚌埠医学院学报, 2014, 39(10): 1418-1420.
[3]	李玉龙 , 彭德峰 , 王自豪 , 王志军 , 董慧明 . 三阴性乳腺癌210例临床分析. 蚌埠医学院学报, 2019, 44(9): 1173-1176, 1181. doi: 10.13898/j.cnki.issn.1000-2200.2019.09.009
[4]	王修军 , 易君 , 张欢欢 . 基于多维度指标建立预测模型在乳腺癌病人腋窝淋巴结转移的应用价值. 蚌埠医学院学报, 2022, 47(8): 1066-1069. doi: 10.13898/j.cnki.issn.1000-2200.2022.08.018
[5]	毛志方 , 张晨光 , 孙学强 , 刘梦汝 . 疏肝健脾中药对肝硬化患者催乳素水平的影响. 蚌埠医学院学报, 2013, 37(2): 149-150;153;150.
[6]	贾梅 , 李檬 , 陈秀芹 . PICC静脉血栓类疾病危险因素预测在肝胆胰恶性肿瘤病人中的研究. 蚌埠医学院学报, 2021, 46(9): 1288-1291, 1294. doi: 10.13898/j.cnki.issn.1000-2200.2021.09.036
[7]	张玮 , 王秋萍 . 绝经后骨质疏松症发病相关危险因素及预防措施研究. 蚌埠医学院学报, 2017, 42(11): 1506-1509. doi: 10.13898/j.cnki.issn.1000-2200.2017.11.022
[8]	刘慧婷 , 王德斌 , 沈兴蓉 , 程静 , 卢曼曼 , 柴静 . 安徽省女性乳腺癌危险因素分析与风险预测模型研究. 蚌埠医学院学报, 2022, 47(5): 661-664. doi: 10.13898/j.cnki.issn.1000-2200.2022.05.026
[9]	汪睿 , 吴坚 . 糖尿病足溃疡危险因素分析. 蚌埠医学院学报, 2015, 40(11): 1496-1500. doi: 10.13898/j.cnki.issn.1000-2200.2015.11.011
[10]	陈永侠 , 杨秀木 , 况静英 , 韩布新 . 乳腺癌手术患者焦虑抑郁状况及相关因素分析. 蚌埠医学院学报, 2009, 34(9): 840-842.
[11]	况敬英 , 周清 , 杨秀木 , 陈永侠 , 韩布新 . 乳腺癌患者配偶焦虑抑郁状况的调查及相关因素分析. 蚌埠医学院学报, 2010, 35(11): 1170-1172.
[12]	周霞 , 张利 . 某市妇女乳腺癌筛查知信行现状及其影响因素. 蚌埠医学院学报, 2012, 36(5): 581-584.
[13]	郑素格 , 张顺花 , 朱伟豪 , 樊婷婷 , 付宝月 , 巨年婷 , 张晓嵽 . 芜湖市高校女大学生乳腺癌知信行现状及影响因素. 蚌埠医学院学报, 2020, 45(11): 1537-1543. doi: 10.13898/j.cnki.issn.1000-2200.2020.11.023
[14]	高洁 , 蒋艳芳 , 吴勇松 , 廖安宇 , 喻大军 . 乳腺癌病人抑郁焦虑情绪测查及影响因素的分析研究. 蚌埠医学院学报, 2024, 49(1): 94-98. doi: 10.13898/j.cnki.issn.1000-2200.2024.01.021
[15]	李玉胜 , 许磊 , 孙岩峰 , 孔祥歆 , 金功圣 . 男性乳腺癌与女性乳腺癌的预后影响因素探讨. 蚌埠医学院学报, 2019, 44(5): 610-613. doi: 10.13898/j.cnki.issn.1000-2200.2019.05.013
[16]	张蓉 , 张静 . 乳腺癌术后化疗病人恐惧疾病进展心理及其影响因素分析. 蚌埠医学院学报, 2019, 44(11): 1545-1548. doi: 10.13898/j.cnki.issn.1000-2200.2019.11.030
[17]	郭斌 . 乳腺癌病人腋窝淋巴结转移相关因素分析. 蚌埠医学院学报, 2021, 46(2): 206-209, 213. doi: 10.13898/j.cnki.issn.1000-2200.2021.02.018
[18]	张新胜 , 马新安 . 老年脑卒中营养不良危险因素分析. 蚌埠医学院学报, 2017, 42(7): 950-951. doi: 10.13898/j.cnki.issn.1000-2200.2017.07.037
[19]	赵雪芬 , 王静 . 自然流产408例危险因素分析. 蚌埠医学院学报, 2016, 41(10): 1340-1343. doi: 10.13898/j.cnki.issn.1000-2200.2016.10.026
[20]	赵武 , 夏群 , 徐家新 . 早产儿血糖紊乱的特点及相关危险因素分析. 蚌埠医学院学报, 2012, 36(8): 913-917.

点击查看大图

计量

文章访问数: 4295
HTML全文浏览量: 404
PDF下载量: 186
被引次数: 0

血浆催乳素水平与绝经前乳腺癌危险性的关系评估

作者简介: 马瑞兰(1981-),女,硕士,主治医师.

大连医科大学附属第二医院肿瘤放疗科, 辽宁大连 116023

收稿日期: 2013-11-27

关键词:

摘要: 目的:评估血浆催乳素(PRL)水平与绝经前女性乳腺癌危险性的关系.方法:采用放射免疫法测定65例绝经前女性乳腺癌患者(病例组)和65例匹配对照者(对照组)的血浆PRL水平,条件logistic回归分析血浆PRL水平与绝经前乳腺癌危险性的关系.根据肿瘤的临床病理特征对病例组再进行分组,评价血浆PRL水平与乳腺癌各亚组危险性的关系.结果:病例组血浆PRL水平显著高于对照组(P < 0.01).血浆PRL水平上四分位数相比下四分位数的调整OR(95%CI)为1.54(0.84～4.07),趋势P=0.031;PRL与绝经前乳腺癌危险性的关系在雌激素受体阳性的肿瘤中稍增强,但不随肿瘤大小、病理类型、肿瘤分级、淋巴结转移情况而变化.结论:血浆PRL水平与绝经前女性乳腺癌的危险性呈正相关,尤其是雌激素受体阳性的乳腺癌患者.